Oncothyreon, Array BioPharma to develop and commercialize ARRY-380 for breast cancer - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
Oncothyreon, Array BioPharma to develop and commercialize ARRY-380 for breast cancer

General Cancer News Latest Breast Cancer News from Moreover Technologies

Reply

05-30-2013, 06:10 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,104	Oncothyreon, Array BioPharma to develop and commercialize ARRY-380 for breast cancer Oncothyreon Inc. and Array BioPharma Inc. today announced that they will collaborate to develop and commercialize ARRY-380, an orally active, reversible and selective small-molecule HER2 inhibitor. More...

Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 03:01 PM.

free webpage hit counter